DAVID WATERSON: Open Payments
NPI 1821666876 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$867 in 38 payments from 17 companies in 2025. Trend: 2023 $571 · 2024 $847 · 2025 $867
Food & beverage: $867
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $138 |
| Boston Scientific Corporation | 4 | $100 |
| Alnylam Pharmaceuticals Inc. | 4 | $92 |
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $78 |
| Actelion Pharmaceuticals US, Inc. | 2 | $53 |
| Inspire Medical Systems, Inc. | 1 | $49 |
| Edwards Lifesciences Corporation | 1 | $41 |
| Merck Sharp & Dohme LLC | 2 | $40 |
| Abbott Laboratories | 2 | $39 |
Products named: VYNDAQEL, WATCHMAN FLX, ONPATTRO, LEQVIO, JARDIANCE, INSPIRE, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, VERQUVO.
Industry payments across MI — which companies pay providers there.
